Despite the known risks, consistent screening for tardive dyskinesia (TD) in outpatient psychiatric settings remains limited, largely due to time constraints, underutilization of standardized tools like the Abnormal...
Jonathan Falletta,
PA-C, CAQ-Psych,
Physician Associate, DENT Neurologic Institute
Tardive Dyskinesia: Challenges in Diagnosis, Management, and Treatment
Tardive dyskinesia (TD) is a complex iatrogenic movement disorder caused by prolonged dopamine receptor antagonism, often occurring in individuals on...
Jonathan Falletta,
PA-C, CAQ-Psych,
Physician Associate, DENT Neurologic Institute
Managing Tardive Dyskinesia: Early Detection and Effective Treatment Strategies
Tardive dyskinesia (TD) is an involuntary movement disorder caused by prolonged use of dopamine receptor-blocking agents, such as antipsychotic medications....
Jessica Jones,
DHSc, PA-C, CAQ-Psych,
Director of Didactic Education, College of Saint Mary
Advances in Tardive Dyskinesia Diagnosis and Treatment: Early Detection and VMAT2 Inhibitors
The clinical manifestations of tardive dyskinesia (TD) can be disruptive, with common symptoms including choreoathetotic and stereotypic movements, particularly in...
Aaron Zalewski,
MSN, PMHNP-BC,
Psychiatric-Mental Health Nurse Practitioner, H3-Hope Healing Health
